Valor20202021202220232024TTMGastos comerciales, generales y administrativos31.34 M32.93 M30.67 M52.71 M61.39 M—Investigación y desarrollo800 K1.2 M1 M800 K700 K—Beneficio operativo4.49 M9.05 M-405 K-964 K1.43 M596 KTotal de ingresos no operativos96 K-381 K-848 K-332 K1.71 M-3.23 MGastos por intereses, netos de intereses capitalizados————475 K—Ingresos no operativos, una vez deducidos los gastos por intereses-1.05 M-158 K-686 K-162 K-1.35 M-3.01 MIngresos/gastos extraordinarios1.15 M-223 K-162 K-170 K2.59 M-457 KBeneficio antes de impuestos5.72 M8.89 M-479 K-1.13 M3.74 M-121 KParticipación en los beneficios——————Impuestos-536 K-950 K4.01 M1.11 M1.25 M1.43 MParticipación minoritaria——————Otros ingresos/gastos después de impuestos——————Beneficio neto antes de actividades interrumpidas6.26 M9.84 M-4.49 M-2.24 M2.49 M-1.55 MOperaciones suspendidas——————Beneficio neto6.26 M9.84 M-4.49 M-2.24 M2.49 M-1.55 MAjuste por dilución——————Dividendos de las acciones preferentes——————Beneficio neto diluido atribuible a los accionistas6.26 M9.84 M-4.49 M-2.24 M2.49 M-1.55 MBeneficio básico por acción2.84.95-2.35-1.21.32-0.87Beneficio por acción diluido2.774.71-2.35-1.21.32-0.87Número medio de acciones ordinarias2.23 M1.99 M1.91 M1.87 M1.89 M—Acciones diluidas2.26 M2.09 M1.91 M1.87 M1.89 M—EBITDA6.56 M10.83 M1.31 M668 K2.21 M1.48 MEBIT4.57 M9.12 M-317 K-960 K675 K307 KCosto de los ingresos35.51 M34.15 M33.06 M29.09 M26.41 M26.14 MOtros costes de producción506 K638 K543 K463 K777 K—Amortización y depreciación (flujo de caja)1.99 M1.72 M1.63 M1.63 M1.53 M1.17 M
Mannatech Incorporated
Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates.
In 2007, Mannatech and its salespeople made false claims of anti-disease benefits about its lead product called "Ambrotose" which contains sugars derived from plants. The company was profitable soon after its founding until about 2008, when it started losing money due to exposure of its business practices through a class action lawsuit based on the false health claims, a critical 20/20 news special, and a civil suit filed by the Attorney General of Texas.